PharmaShots | Incisive News in 3 Shots

Subscribe Now

aTyr Pharma

aTyr Pharma, Efzofitimod, Systemic Sclerosis-Associated Interstitial Lung Disease, Clinical Trial, P-II Study

aTyr Pharma, Efzofitimod, Systemic Sclerosis-Associated Interstitial Lung Disease, Clinical Trial, P-II Study

March 2, 2023

aTyr Pharma Reports the First Patient Dosing in the P-III (EFZO-FIT) Study of Efzofitimod for the Treatment of Pulmonary Sarcoidosis

aTyr Pharma Reports the First Patient Dosing in the P-III (EFZO-FIT) Study of Efzofitimod for the Treatment of Pulmonary Sarcoidos...

September 28, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us